{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:58:17Z","timestamp":1791093497644,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1245\/s10434-012-2790-8","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T06:14:09Z","timestamp":1362204849000},"page":"1101-1104","source":"Crossref","is-referenced-by-count":11,"title":["Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"20","author":[{"given":"Joshua C.","family":"Leinwand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleneara E.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Allendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharyn N.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"2790_CR1","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/annonc\/mdh398","volume":"15","author":"D Elias","year":"2004","unstructured":"Elias D, Matsuhisa T, Sideris L. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol. 2004;15:1558\u201365.","journal-title":"Ann Oncol."},{"key":"2790_CR2","first-page":"1","volume":"62","author":"RL Dedrick","year":"1978","unstructured":"Dedrick RL, Myers CE, Bungay PM, DeVita VT Jr. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978;62:1\u201311.","journal-title":"Cancer Treat Rep."},{"key":"2790_CR3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1023\/B:PHAM.0000026444.67883.83","volume":"21","author":"E Jerremalm","year":"2004","unstructured":"Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res. 2004;21:891\u20134.","journal-title":"Pharm Res."},{"key":"2790_CR4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00228-008-0511-9","volume":"64","author":"H Mahteme","year":"2008","unstructured":"Mahteme H, Wallin I, Glimelius B, P\u00e5hlman L, Ehrsson H. Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion. Eur J Clin Pharmacol. 2008;64:907\u201311.","journal-title":"Eur J Clin Pharmacol."},{"key":"2790_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/026765919901400208","volume":"14","author":"LB Mongero","year":"1999","unstructured":"Mongero LB, Beck JR, Kroslowitz RM, Argenziano M, Chabot JA. Treatment of primary peritoneal mesothelioma by hyperthermic intraperitoneal chemotherapy. Perfusion. 1999;14:141\u20135.","journal-title":"Perfusion."},{"key":"2790_CR6","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1245\/s10434-008-9967-1","volume":"15","author":"JH Stewart 4th","year":"2008","unstructured":"Stewart JH 4th, Shen P, Russell G, Fenstermaker J, McWilliams L, Coldrun FM, et al. A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers. Ann Surg Oncol. 2008;15:2137\u201345.","journal-title":"Ann Surg Oncol."},{"key":"2790_CR7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0952-8180(92)90111-D","volume":"4","author":"Y Wang","year":"1992","unstructured":"Wang Y, Moss J, Thisted R. Predictors of body surface area. J Clin Anesth. 1992;4:4\u201310.","journal-title":"J Clin Anesth."},{"key":"2790_CR8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221:124\u201332.","journal-title":"Ann Surg."},{"key":"2790_CR9","first-page":"530","volume":"181","author":"P Jacquet","year":"1995","unstructured":"Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg. 1995;181:530\u20138.","journal-title":"J Am Coll Surg."},{"key":"2790_CR10","first-page":"183","volume":"104","author":"RJ Baker","year":"1957","unstructured":"Baker RJ, Kozoll DD, Meyer KA. The use of surface area as a basis for establishing normal blood volume. Surg Gynecol Obstet. 1957;104:183\u20139.","journal-title":"Surg Gynecol Obstet."},{"key":"2790_CR11","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.V4101820","volume":"4","author":"P Keshaviah","year":"1994","unstructured":"Keshaviah P, Emerson PF, Vonesh EF, Brandes JC. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol. 1994;4:1820\u20136.","journal-title":"J Am Soc Nephrol."},{"key":"2790_CR12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0003-4975(00)02393-6","volume":"71","author":"GR DeFoe","year":"2001","unstructured":"DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 2001;71:769\u201376.","journal-title":"Ann Thorac Surg."},{"key":"2790_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00280-003-0626-8","volume":"52","author":"Vazquez V Lima de","year":"2003","unstructured":"de Lima Vazquez V, Stuart OA, Mohamed F, Sugarbaker PH. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol. 2003;52:108\u201312.","journal-title":"Cancer Chemother Pharmacol."},{"key":"2790_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","volume":"13","author":"D Elias","year":"2002","unstructured":"Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002;13:267\u201372.","journal-title":"Ann Oncol."},{"key":"2790_CR15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0b013e3182193143","volume":"254","author":"N Pich\u00e9","year":"2011","unstructured":"Pich\u00e9 N, Leblond FA, Sid\u00e9ris L, Pichette V, Drolet P, Fortier LP, et al. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model. Ann Surg. 2011;254:138\u201344.","journal-title":"Ann Surg."},{"key":"2790_CR16","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1245\/s10434-010-0937-z","volume":"17","author":"P Ortega-Deballon","year":"2010","unstructured":"Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol. 2010;17:1957\u201363.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2790-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2790-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T22:49:55Z","timestamp":1644446995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2790-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2790"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2790-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]}}}